Jianqiang Yu Selected Research

Jianqiang Yu Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 03/2007
5	Reperfusion Injury 04/2020 - 05/2013
4	Pain (Aches) 01/2022 - 01/2010
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2016
4	Neuralgia (Stump Neuralgia) 01/2020 - 08/2013
3	Brain Ischemia (Cerebral Ischemia) 04/2020 - 05/2013
3	Parkinson Disease (Parkinson's Disease) 03/2018 - 01/2016
2	Lung Neoplasms (Lung Cancer) 11/2021 - 08/2021
2	Inflammation (Inflammations) 10/2021 - 01/2016
2	Necrosis 01/2021 - 01/2020
2	Cerebral Infarction 08/2020 - 05/2013
2	Ischemia 01/2020 - 03/2018
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 01/2014
2	Pulmonary Hypertension 11/2017 - 05/2017
2	Breast Neoplasms (Breast Cancer) 06/2013 - 01/2012
2	Neoplasm Metastasis (Metastasis) 06/2013 - 03/2007
1	Infertility (Sterility) 10/2022
1	Erectile Dysfunction 10/2022
1	Vomiting 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Chronic Pain 01/2022
1	Carcinogenesis 11/2021
1	Acute Lung Injury 10/2021
1	Ototoxicity 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Intractable Pain 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Hyperalgesia 10/2019
1	Epilepsy (Aura) 04/2019
1	Seizures (Absence Seizure) 04/2019
1	Stroke (Strokes) 03/2018
1	Brain Injuries (Brain Injury) 11/2017
1	Central Nervous System Diseases (CNS Diseases) 01/2017
1	Weight Loss (Weight Reduction) 05/2015

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2003
6	Neuroprotective AgentsIBA 04/2020 - 05/2013
4	AlkaloidsIBA 10/2022 - 11/2017
3	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 11/2021 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 06/2009
2	CarcinogensIBA 11/2021 - 08/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
2	oxymatrineIBA 08/2020 - 08/2013
2	Oxygen (Dioxygen)IBA 01/2019 - 11/2017
2	MonocrotalineIBA 11/2017 - 05/2017
2	aloperineIBA 11/2017 - 05/2017
2	Nimodipine (Modus)FDA LinkGeneric 01/2014 - 05/2013
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2013 - 05/2013
2	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 06/2013 - 01/2012
2	Acetic Acid (Vinegar)FDA LinkGeneric 06/2013 - 01/2010
2	oxysophoridineIBA 05/2013 - 01/2012
1	IridoidsIBA 10/2022
1	GlycosidesIBA 10/2022
1	LignansIBA 10/2022
1	Phenylethyl Alcohol (Phenethyl Alcohol)IBA 10/2022
1	Polysaccharides (Glycans)IBA 10/2022
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Nitrous Oxide (Laughing Gas)IBA 01/2022
1	Glycine Plasma Membrane Transport ProteinsIBA 01/2022
1	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 11/2021
1	allyl sulfideIBA 11/2021
1	EnzymesIBA 11/2021
1	Epichlorohydrin (Epichlorhydrin)IBA 10/2021
1	Protective AgentsIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	SmokeIBA 08/2021
1	KW 2449IBA 01/2021
1	PlatinumIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	swertiamarinIBA 04/2020
1	N- (4- methyl- 3- (1- methyl- 7- (6- methylpyridin- 3- ylamino)- 2- oxo- 1,2- dihydropyrimido(4,5- d)pyrimidin- 3(4H)- yl)phenyl)- 3- (trifluoromethyl)benzamideIBA 01/2020
1	CaspasesIBA 01/2020
1	Plant ExtractsIBA 01/2020
1	FlavonoidsIBA 10/2019
1	AntioxidantsIBA 10/2019
1	homoorientin (isoorientin)IBA 10/2019
1	baldrinalIBA 04/2019
1	NMDA receptor A1IBA 04/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2019
1	Pilocarpine (Ocusert)FDA LinkGeneric 04/2019
1	anethole (trans-anethole)IBA 12/2018
1	Cytidine Diphosphate (CDP)IBA 03/2018
1	NitrogenIBA 11/2017
1	ChitosanIBA 11/2017
1	OligosaccharidesIBA 11/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	alloinIBA 03/2016
1	Trihexyphenidyl (Artane)FDA LinkGeneric 01/2016
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2016

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2012
2	Oral Administration 01/2021 - 11/2017
1	Analgesia 01/2022
1	Immunotherapy 01/2022
1	Chemoprevention 11/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Ligation 11/2017